Migraine Trial, Recruiting NCT05669703 Sponsor: National Institute of Mental Health (NIMH) Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT05669703
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are willing to take part in all study activities and are available for the full length of the study
  • You are 8 years old or older
  • If you are the main participant (called a "proband"), at least one close family member (such as a parent, sibling, or child) must also agree to join the study
  • If you are the main participant who has experienced a mood disorder, you must have been diagnosed with a mood disorder at some point in your life
  • If you are the main participant who has not experienced a mood disorder, you must have no history of a mood disorder at any point in your life
  • You are in generally good health based on your medical history
  • You agree to follow certain lifestyle guidelines throughout the study
  • You (or your legal guardian or representative) are able to understand and are willing to sign a consent form

Who may not be able to join:

  • You are currently pregnant
  • You are currently going through a severe episode of mania or depression — though this does not permanently exclude you, and you may be able to join once your symptoms are well enough managed to allow participation (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kathleen R Merikangas, Ph.D., National Institute of Mental Health (NIMH)

Phone: (301) 496-7773

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 November 2023
Est. completion
31 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Scores on standardized questionnaires; Subjective mood and energy ratings; Clinical rating scales

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov